Evaluating the Safety and Efficacy of Duloxetine in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis

PHASE3RecruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

March 10, 2025

Primary Completion Date

June 20, 2025

Study Completion Date

July 10, 2025

Conditions
Biliary Disease
Interventions
DRUG

Duloxetine

Duloxetine, a non-opioid neuromodulator, has been widely used to manage neuropathic pain. It possesses dual central and peripheral analgesic properties

OTHER

Placebo capsule

Placebo will have the same look and appearance of active comparator

Trial Locations (1)

31527

RECRUITING

Tanta Unuversity, Tanta

All Listed Sponsors
lead

Tanta University

OTHER